Loading stock data…
Loading stock data…
US$0.25
Get one email when ATXI crosses your level. Checked every 15 minutes during market hours.
▼ -0.01 (-3.85%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
38.5
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
-0.01
Bearish momentumMACD below its signal line (-0.01).
50-day average
0.33
Price belowShort-term trend reference.
200-day average
0.48
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Avenue Therapeutics is a specialty pharmaceutical company focused on developing and commercializing therapies for treating neurologic diseases. The company is headquartered in Bay Harbor Islands, Florida and operates as a subsidiary of Fortress Biotech. Avenue Therapeutics pursues a focused pipeline of product candidates designed to address serious neurological conditions. These include AJ201, currently in clinical development for spinal and bulbar muscular atrophy, intravenous tramadol for post…
avenuetx.com2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-05-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-04-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-03-01)
2 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2025-02-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-03-04 | 0.06 | 0.15 | ✓ Beat |
| 2025-10-23 | -0.3 | -0.19 | ✓ Beat |
| 2024-11-14 | -0.94 | -1.92 | ✗ Miss |
| 2024-08-09 | -1.05 | -2.41 | ✗ Miss |
| 2024-05-14 | -9 | -15.4 | ✗ Miss |
| 2024-03-18 | -7.5 | 42 | ✓ Beat |
| 2023-11-13 | -19.5 | 4.5 | ✓ Beat |
Companies in the same industry, via Finnhub